Systemic sclerosis & Raynaud's

Cross-validation and sensitivity to change of EULAR ScleroID as a measure of function and impact of disease in patients with systemic sclerosis

RMD OpenPublished Prospective observational cohort study

Authors' conclusion

ScleroID demonstrates strong correlation with validated clinical measures and responsiveness to changes in standard of care, supporting its use in both clinical practice and trials. ScleroID captures the multidimensional burden of SSc regardless of disease subsets.

Study context

Population
Patients with systemic sclerosis (SSc) and ScleroID questionnaires from the observational cohort STRIKE
Participants
271 patients
Exposure
ScleroID across very early, limited and diffuse cutaneous SSc subsets
  • VeSScn = 69
  • lcSScn = 139
  • dcSScn = 63
Outcome
ScleroID score
Methodological detailsobservational cohort (STRIKE), 12-month follow-up
  • Observational cohort (STRIKE)
  • 12-month follow-up

Main finding

As reported in the abstract

VeSSc

2.1

median · IQR 3.6

lcSSc

3.4

median · IQR 4.4

dcSSc

4.7

median · IQR 4

P < 0.001

Observational data: associations, not effects.

Further findings

ScleroID by disease activity

Patients with high disease activity had significantly higher ScleroID scores than low ones
P = 0.003

ScleroID domains by digital ulcers, pulmonary disease or SIBO

Higher scores in their relative domains
P < 0.005 for all

Correlation with other patient-reported outcomes (PROs)

High correlations of ScleroID and its domains with all other PROs
P < 0.05

Sensitivity to change · 12 months

Changes in ScleroID strongly correlated with changes in clinical measures and other PROs; thresholds identified for minimal clinically important difference (MCID) changes in HAQ-DI, UCLA SCTC GIT 2.0 and Cochin Hand Function Scale

Original publication

Cross-validation and sensitivity to change of EULAR ScleroID as a measure of function and impact of disease in patients with systemic sclerosis. RMD Open. Published 10 October 2025. doi:10.1136/rmdopen-2025-005999

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.